Hypertensive disorders of pregnancy: term and conditions.
View / Open Files
Authors
Publication Date
2021-12-26Journal Title
BJOG
ISSN
1470-0328
Publisher
Wiley
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Smith, G. (2021). Hypertensive disorders of pregnancy: term and conditions.. BJOG https://doi.org/10.1111/1471-0528.17080
Abstract
Hypertensive disorders of pregnancy (HDP) are a significant cause of maternal morbidity and mortality. Prophylactic low dose aspirin reduces the risk of preterm preeclampsia but does not prevent disease at term (Rolnik et al. N Engl J Med 2017;377:613-22). The ultimate – and unsophisticated – “cure” for preeclampsia is delivery. In the context of preterm disease, there is a balancing act between the protective effect of delivery on the mother versus the potential adverse effect of exposing the infant to the major determinant of neonatal morbidity, namely, prematurity. However, for disease at term, delivery reduces risks to the mother and is much more benign for the infant, particularly if effected at 39 weeks of gestational age (wkGA) or later. Hence, the low hanging fruit in screening and prevention of HDP is disease manifesting at term (Smith GCS. PLoS Med 2012;9:e1001274).
Sponsorship
This work was supported by the NIHR Cambridge Biomedical Research Centre
Funder references
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
National Institute for Health Research (NIHRDH-IS-BRC-1215-20014)
Embargo Lift Date
2022-12-26
Identifiers
External DOI: https://doi.org/10.1111/1471-0528.17080
This record's URL: https://www.repository.cam.ac.uk/handle/1810/332661
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.